Literature DB >> 29451444

Survival and prognostic factors in cats with restrictive cardiomyopathy: a review of 90 cases.

Chiara Locatelli1, Danitza Pradelli2, Giulia Campo1, Ilaria Spalla3, Alice Savarese1, Paola G Brambilla1, Claudio Bussadori2.   

Abstract

OBJECTIVES: Large studies focusing on restrictive cardiomyopathy (RCM) in the cat are scarce. The aims of this retrospective study were to describe epidemiological characteristics and to analyse prognostic factors affecting survival in cats with RCM.
METHODS: The clinical archives of the Gran Sasso Veterinary Clinic (Milan, Italy) and of the cardiology unit of the Department of Veterinary Medicine (University of Milan, Italy) from 1997-2015 were reviewed for all cats diagnosed with RCM based on an echocardiographic examination (left atrial/biatrial enlargement, normal left ventricle wall thickness, normal or mildly decreased systolic function and restrictive left ventricle filling pattern with pulsed Doppler echocardiography).
RESULTS: The study population comprised 90 cats (53 male, 37 female) with an echocardiographic diagnosis of RCM. Most were domestic shorthairs (n = 60) with a mean ± SD age of 10.0 ± 4.3 years and a median weight of 3.8 kg (interquartile range 3.2-5 kg). Most cats were symptomatic (n = 87). The most common clinical sign was respiratory distress (n = 75). Follow-up was available for 60 cats and the median survival time (MST) was 69 days (95% confidence interval [CI] 0-175 days). Cardiac-related death occurred in 50 cats. In the multivariate Cox analysis only respiratory distress showed a statistically significant effect on survival. The cats without respiratory distress showed an MST of 466 days (95% CI 0-1208); cats with respiratory distress showing an MST of 64 days (95% CI 8-120; P = 0.011). CONCLUSIONS AND RELEVANCE: RCM can be considered an end-stage condition associated with a poor prognosis, with few cats not showing clinical signs and surviving >1 year. Most cats died of cardiac disease within a very short time.

Entities:  

Mesh:

Year:  2018        PMID: 29451444     DOI: 10.1177/1098612X18755955

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  10 in total

1.  Comparative assessment of left atrial volume in healthy cats by two-dimensional and three-dimensional echocardiography.

Authors:  Janina Rauch; Michael Fehr; Martin Beyerbach; Stephan O Hungerbuehler
Journal:  BMC Vet Res       Date:  2020-07-29       Impact factor: 2.741

2.  Clinical, epidemiological and echocardiographic features and prognostic factors in cats with restrictive cardiomyopathy: A retrospective study of 92 cases (2001-2015).

Authors:  Valérie Chetboul; Peggy Passavin; Emilie Trehiou-Sechi; Vassiliki Gouni; Camille Poissonnier; Jean-Louis Pouchelon; Loic Desquilbet
Journal:  J Vet Intern Med       Date:  2019-03-28       Impact factor: 3.333

3.  Decreased Left Atrial Reservoir Strain Is Associated with Adverse Outcomes in Restrictive Cardiomyopathy.

Authors:  Jadranka Stojanovska; Nevriye Topaloglu; Kana Fujikura; Behnaz Khazai; El-Sayed Ibrahim; Alex Tsodikov; Nicole M Bhave; Theodore J Kolias
Journal:  J Clin Med       Date:  2022-07-15       Impact factor: 4.964

4.  Left and Right Myocardial Functionality Assessed by Two-Dimensional Speckle-Tracking Echocardiography in Cats with Restrictive Cardiomyopathy.

Authors:  Ryohei Suzuki; Yunosuke Yuchi; Haruka Kanno; Takahiro Teshima; Hirotaka Matsumoto; Hidekazu Koyama
Journal:  Animals (Basel)       Date:  2021-05-28       Impact factor: 2.752

5.  ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats.

Authors:  Virginia Luis Fuentes; Jonathan Abbott; Valérie Chetboul; Etienne Côté; Philip R Fox; Jens Häggström; Mark D Kittleson; Karsten Schober; Joshua A Stern
Journal:  J Vet Intern Med       Date:  2020-04-03       Impact factor: 3.333

6.  Retrospective evaluation of the safety and tolerability of pimobendan in cats with obstructive vs nonobstructive cardiomyopathy.

Authors:  Jessica L Ward; Efrem Z Kussin; Melissa A Tropf; Sandra P Tou; Teresa C DeFrancesco; Bruce W Keene
Journal:  J Vet Intern Med       Date:  2020-10-07       Impact factor: 3.333

7.  Effect of angiotensin receptor blockers and angiotensin-converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in cats with heart disease.

Authors:  Terry Huh; Éva Larouche-Lebel; Kerry A Loughran; Mark A Oyama
Journal:  J Vet Intern Med       Date:  2020-11-02       Impact factor: 3.175

8.  The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy.

Authors:  Mark D Kittleson; Etienne Côté
Journal:  J Feline Med Surg       Date:  2021-11       Impact factor: 2.015

9.  The Feline Cardiomyopathies: 3. Cardiomyopathies other than HCM.

Authors:  Mark D Kittleson; Etienne Côté
Journal:  J Feline Med Surg       Date:  2021-11       Impact factor: 2.015

10.  The Feline Cardiomyopathies: 1. General concepts.

Authors:  Mark D Kittleson; Etienne Côté
Journal:  J Feline Med Surg       Date:  2021-11       Impact factor: 2.015

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.